BMO Capital Downgrades Regado Biosciences (RGDO) to Underperform; $1 Price Target
Tweet Send to a Friend
BMO Capital downgraded Regado Biosciences (NASDAQ: RGDO) from Outperform to Underperform with a price target of $1.00.Analyst Jim Birchenough, M.D ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
